Denise A. Egan

3.4k total citations · 1 hit paper
36 papers, 2.7k citations indexed

About

Denise A. Egan is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Denise A. Egan has authored 36 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Organic Chemistry and 10 papers in Molecular Biology. Recurrent topics in Denise A. Egan's work include Metal complexes synthesis and properties (17 papers), Synthesis and biological activity (6 papers) and Crystal structures of chemical compounds (6 papers). Denise A. Egan is often cited by papers focused on Metal complexes synthesis and properties (17 papers), Synthesis and biological activity (6 papers) and Crystal structures of chemical compounds (6 papers). Denise A. Egan collaborates with scholars based in Ireland, United Kingdom and United States. Denise A. Egan's co-authors include Bernadette S. Creaven, Richard O’Kennedy, Malachy McCann, Gregory J. Finn, Maureen Walsh, Kevin Kavanagh, Michael Devereux, R. D. Thornes, Dermot Cox and Ena Prosser and has published in prestigious journals such as Analytica Chimica Acta, Biochemical Pharmacology and Sensors and Actuators B Chemical.

In The Last Decade

Denise A. Egan

36 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Pharmacology, Metabolism, Analysis, and Applications of Coumarin and Coumarin-Related Compounds

1990 468 citations Denise A. Egan, Richard O’Kennedy et al. Drug Metabolism Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Denise A. Egan Ireland	27	1.4k	1.2k	600	496	307	36	2.7k
Bernadette S. Creaven Ireland	30	1.6k 1.1×	1.2k 1.0×	503 0.8×	543 1.1×	480 1.6×	68	2.7k
Lallan Mishra India	24	948 0.7×	805 0.7×	398 0.7×	364 0.7×	475 1.5×	165	2.0k
Patrick J. Bednarski Germany	35	2.2k 1.5×	1.6k 1.4×	1.4k 2.4×	340 0.7×	634 2.1×	164	4.2k
Jaromı́r Marek Czechia	29	1.2k 0.8×	987 0.8×	593 1.0×	1.3k 2.5×	811 2.6×	207	3.2k
Jean‐Didier Maréchal Spain	37	1.2k 0.8×	749 0.6×	1.5k 2.5×	869 1.8×	538 1.8×	156	3.6k
Vedavati G. Puranik India	38	3.0k 2.1×	1.3k 1.1×	1.2k 2.0×	908 1.8×	763 2.5×	242	4.8k
S.K. Kar India	31	662 0.5×	881 0.7×	543 0.9×	634 1.3×	460 1.5×	93	2.5k
Simón Hernández‐Ortega Mexico	30	2.6k 1.8×	1.5k 1.3×	417 0.7×	1.4k 2.8×	589 1.9×	281	4.0k
Kishwar Saleem India	23	1.1k 0.8×	783 0.7×	593 1.0×	210 0.4×	215 0.7×	54	2.4k
Sajjad Hussain Sumrra Pakistan	37	2.1k 1.5×	1.3k 1.1×	354 0.6×	365 0.7×	517 1.7×	132	3.3k

Countries citing papers authored by Denise A. Egan

Since Specialization

Citations

This map shows the geographic impact of Denise A. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise A. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise A. Egan more than expected).

Fields of papers citing papers by Denise A. Egan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise A. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise A. Egan. The network helps show where Denise A. Egan may publish in the future.

Co-authorship network of co-authors of Denise A. Egan

This figure shows the co-authorship network connecting the top 25 collaborators of Denise A. Egan. A scholar is included among the top collaborators of Denise A. Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise A. Egan. Denise A. Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nimir, Hassan, Darren M. Griffith, Brian Duff, et al.. (2013). A novel platinum complex of the histone deacetylase inhibitor belinostat: Rational design, development and in vitro cytotoxicity. Journal of Inorganic Biochemistry. 124. 70–77. 28 indexed citations

Griffith, Darren M., Brian Duff, Kyrill Yu. Suponitsky, et al.. (2011). Novel trans-platinum complexes of the histone deacetylase inhibitor valproic acid; synthesis, in vitro cytotoxicity and mutagenicity. Journal of Inorganic Biochemistry. 105(6). 793–799. 41 indexed citations

Creaven, Bernadette S., Denise A. Egan, Dariusz Karcz, et al.. (2007). Synthesis, characterisation and antimicrobial activity of copper(II) and manganese(II) complexes of coumarin-6,7-dioxyacetic acid (cdoaH2) and 4-methylcoumarin-6,7-dioxyacetic acid (4-MecdoaH2): X-ray crystal structures of [Cu(cdoa)(phen)2]·8.8H2O and [Cu(4-Mecdoa)(phen)2]·13H2O (phen=1,10-phenanthroline). Journal of Inorganic Biochemistry. 101(8). 1108–1119. 70 indexed citations

Deegan, C., Barry Coyle, Malachy McCann, Michael Devereux, & Denise A. Egan. (2006). In vitro anti-tumour effect of 1,10-phenanthroline-5,6-dione (phendione), [Cu(phendione)3](ClO4)2·4H2O and [Ag(phendione)2]ClO4 using human epithelial cell lines. Chemico-Biological Interactions. 164(1-2). 115–125. 87 indexed citations

Deegan, C., Malachy McCann, Michael Devereux, Barry Coyle, & Denise A. Egan. (2006). In vitro cancer chemotherapeutic activity of 1,10-phenanthroline (phen), [Ag2(phen)3(mal)]·2H2O, [Cu(phen)2(mal)]·2H2O and [Mn(phen)2(mal)]·2H2O (malH2=malonic acid) using human cancer cells. Cancer Letters. 247(2). 224–233. 106 indexed citations

Devereux, Michael, Malachy McCann, Denis O′Shea, et al.. (2005). Synthesis, Superoxide Dismutase Mimetic and Anticancer Activities of Metal Complexes of 2,2‐Dimethylpentanedioic Acid(2dmepdaH2) and 3,3‐Dimethylpentanedioic acid(3dmepdaH2): X‐Ray Crystal Structures of [Cu(3dmepda)(bipy)]2 · 6H₂O and [Cu(2dmepda)(bipy)(EtOH)]2 · 4EtOH(bipy=2, 2^′Bipyridine). Bioinorganic Chemistry and Applications. 2006(1). 80283–80283. 27 indexed citations

Finn, Gregory J., Bernadette S. Creaven, & Denise A. Egan. (2005). Activation of mitogen activated protein kinase pathways and melanogenesis by novel nitro-derivatives of 7-hydroxycomarin in human malignant melanoma cells. European Journal of Pharmaceutical Sciences. 26(1). 16–25. 47 indexed citations

Finn, Gregory J., Bernadette S. Creaven, & Denise A. Egan. (2004). A study of the role of cell cycle events mediating the action of coumarin derivatives in human malignant melanoma cells. Cancer Letters. 214(1). 43–54. 45 indexed citations

Finn, Gregory J., Bernadette S. Creaven, & Denise A. Egan. (2004). Daphnetin induced differentiation of human renal carcinoma cells and its mediation by p38 mitogen-activated protein kinase. Biochemical Pharmacology. 67(9). 1779–1788. 75 indexed citations

10.

Coyle, Barry, Malachy McCann, Kevin Kavanagh, et al.. (2004). Synthesis, X-ray crystal structure, anti-fungal and anti-cancer activity of [Ag2(NH3)2(salH)2] (salH2=salicylic acid). Journal of Inorganic Biochemistry. 98(8). 1361–1366. 84 indexed citations

11.

Egan, Denise A., et al.. (2003). High Performance Liquid Chromatographic Determination of Esculetin and Daphnetin in Urine and Plasma. Chromatographia. 58(9-10). 649–652. 8 indexed citations

12.

Finn, Gregory J., Bernadette S. Creaven, & Denise A. Egan. (2003). Investigation of intracellular signalling events mediating the mechanism of action of 7-hydroxycoumarin and 6-nitro-7-hdroxycoumarin in human renal cells. Cancer Letters. 205(1). 69–79. 31 indexed citations

13.

Finn, Gregory J., Bernadette S. Creaven, & Denise A. Egan. (2003). Modulation of mitogen-activated protein kinases by 6-nitro-7-hydroxycoumarin mediates apoptosis in renal carcinoma cells. European Journal of Pharmacology. 481(2-3). 159–167. 50 indexed citations

14.

Finn, Gregory J., et al.. (2002). In vitro cytotoxic potential and mechanism of action of selected coumarins, using human renal cell lines. Cancer Letters. 183(1). 61–68. 111 indexed citations

15.

Finn, Greg, Bernadette S. Creaven, & Denise A. Egan. (2001). Study of the in vitro cytotoxic potential of natural and synthetic coumarin derivatives using human normal and neoplastic skin cell lines. Melanoma Research. 11(5). 461–467. 83 indexed citations

16.

Egan, Denise A., et al.. (1997). Studies on the cytostatic and cytotoxic effects and mode of action of 8-nitro-7-hydroxycoumarin. Cancer Letters. 118(2). 201–211. 111 indexed citations

17.

Dempsey, Eithne, Ciara O’Sullivan, Malcolm R. Smyth, et al.. (1993). Differential pulse voltammetric determination of 7-hydroxycoumarin in human urine. Journal of Pharmaceutical and Biomedical Analysis. 11(6). 443–446. 13 indexed citations

18.

Dempsey, Eithne, Ciara O’Sullivan, Malcolm R. Smyth, et al.. (1993). Development of an antibody-based amperometric biosensor to study the reaction of 7-hydroxycoumarin with its specific antibody. The Analyst. 118(4). 411–411. 14 indexed citations

19.

Egan, Denise A. & Richard O’Kennedy. (1992). Rapid and sensitive determination of coumarin and 7-hydroxycoumarin and its glucuronide conjugate in urine and plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 582(1-2). 137–143. 42 indexed citations

20.

Egan, Denise A., Richard O’Kennedy, Elizabeth Morán, et al.. (1990). The Pharmacology, Metabolism, Analysis, and Applications of Coumarin and Coumarin-Related Compounds. Drug Metabolism Reviews. 22(5). 503–529. 468 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact